Macrolide resistance in Mycoplasma pneumoniae in adult patients

Panpan Xie1,2, Yue Zhang1,3, Yanhong Qin1,3

  • 1Department of Respiratory and Critical Care Medicine, Senior Department of Infectious Diseases, the Fifth Medical Center of PLA General Hospital, Beijing, China.

Insights

Macrolide-resistant Mycoplasma pneumoniae is common in adults, primarily due to 23S rRNA gene mutations. Efflux pumps also contribute to resistance, suggesting midecamycin as a potential alternative treatment.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Mycoplasma pneumoniae causes significant respiratory infections.
  • Macrolides are first-line treatments, but resistance is increasing.
  • Resistance mechanisms in adults remain understudied compared to pediatric cases.

Purpose of the Study:

  • To investigate macrolide resistance in M. pneumoniae from adult patients.
  • To elucidate the underlying resistance mechanisms in adult isolates.
  • To evaluate potential alternative treatments.

Main Methods:

  • Collected pharyngeal swabs from adult patients with respiratory infections.
  • Isolated and identified M. pneumoniae strains.
  • Assessed antimicrobial susceptibility using broth microdilution.
  • Sequenced 23S rRNA genes and performed PCR for resistance genes (erm, mef, mphC).
  • Determined Minimum Inhibitory Concentrations (MICs) with and without reserpine.

Main Results:

  • 41.7% of 72 M. pneumoniae isolates were macrolide-resistant.
  • All resistant strains had mutations at the 2063 site in the 23S rRNA gene.
  • Efflux pump genes (msrA/B, mefA) were found in two isolates.
  • Reserpine reduced azithromycin MICs by 75% in these two strains.
  • Midecamycin showed the greatest activity against M. pneumoniae (MIC90: 16 µg/ml).

Conclusions:

  • Macrolide-resistant M. pneumoniae is prevalent in adult patients in Beijing.
  • Point mutations in the 23S rRNA gene are the primary resistance mechanism.
  • Efflux pumps play a partial role in macrolide resistance.
  • Midecamycin is a promising alternative for treating M. pneumoniae infections, especially azithromycin-resistant cases.

Related Concept Videos

Genomic DNA in Prokaryotes00:46

Genomic DNA in Prokaryotes

The genome of most prokaryotic organisms consists of double-stranded DNA organized into one circular chromosome in a region of cytoplasm called the nucleoid. The chromosome is tightly wound, or supercoiled, for efficient storage. Prokaryotes also contain other circular pieces of DNA called plasmids. These plasmids are smaller than the chromosome and often carry genes that confer adaptive functions, such as antibiotic resistance.
Genomic Diversity in Bacteria
Although bacterial genomes are much...
43.2K
Antibiotic Selection00:57

Antibiotic Selection

Overview
52.0K
Bacterial Transformation01:33

Bacterial Transformation

In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
54.9K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Mismatch Repair01:36

Mismatch Repair

Overview
39.8K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K